| Literature DB >> 35004525 |
Abstract
PURPOSE: This study examined the effects of a breastfeeding coaching program for mothers on growth and neonatal jaundice in late preterm infants (LPIs).Entities:
Keywords: Breast feeding; Coaching; Growth; Neonatal jaundice; Premature infant
Year: 2021 PMID: 35004525 PMCID: PMC8650952 DOI: 10.4094/chnr.2021.27.4.377
Source DB: PubMed Journal: Child Health Nurs Res ISSN: 2287-9110
General and Clinical Characteristics of Participants (N=40)
| Subjects | Variables | Categories | Cont. (n=19) | Exp. (n=21) |
| |
|---|---|---|---|---|---|---|
| n (%) or M±SD | n (%) or M±SD | |||||
| Infant | Sex | Male | 6 (31.6) | 13 (61.9) | 3.68 | .055 |
| Female | 13 (68.4) | 8 (38.1) | ||||
| Gestational age (week) | 34 | 13 (68.4) | 12 (57.1) | 1.03 | .596 | |
| 35 | 5 (26.3) | 6 (28.6) | ||||
| 36 | 1 (5.3) | 3 (14.3) | ||||
| Birth order | First | 11 (57.9) | 14 (66.7) | 0.33 | .567 | |
| Second | 8 (42.1) | 7 (33.3) | ||||
| Number of babies | Singleton | 9 (47.4) | 13 (61.9) | 0.85 | .356 | |
| Twin | 10 (52.6) | 8 (38.1) | ||||
| Type of birth | NSVD | 3 (15.8) | 4 (19.0) | 0.07 | .787 | |
| C-sec | 16 (84.2) | 17 (81.0) | ||||
| Birth weight (g) | 2,296±389 | 2,156±280 | 1.31 | .197 | ||
| Apgar score | 1-minute | 7.42±0.90 | 6.81±1.36 | 1.65 | .107 | |
| 5-minute | 8.68±0.58 | 8.33±0.91 | 1.43 | .160 | ||
| Ventilator | No | 10 (52.6) | 9 (42.9) | 0.38 | .537 | |
| Yes | 9 (47.4) | 12 (57.1) | ||||
| Phototherapy | No | 15 (79.0) | 11 (52.4) | 3.09 | .079 | |
| Yes | 4 (21.0) | 10 (47.6) | ||||
| Tube feeding | No | 8 (42.1) | 7 (33.3) | 0.33 | .567 | |
| Yes | 11 (57.9) | 14 (66.7) | ||||
| Mother | Age (year) | 34.0±3.1 | 33.3±4.2 | 0.61 | .546 | |
| Employed | No | 13 (68.4) | 11 (52.4) | 1.07 | .301 | |
| Yes | 6 (31.6) | 10 (47.6) | ||||
| Obstetric disease | No | 17 (89.5) | 16 (76.2) | 1.22 | .270 | |
| Yes | 2 (10.5) | 5 (23.8) |
Cont., control group; C-sec, cesarean section; Exp., experimental group; NSVD, normal spontaneous vaginal delivery.
Comparison of Feeding Methods between the Groups Over Time (N=40)
| Time | Categories | Cont.[ | Exp.[ | Cont.×Exp.[ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n (%) | OR | 95% CI | z ( | n (%) | OR | 95% CI | z ( | OR | 95%CI | z ( | ||
| Discharge | Breastfeeding | 13 (68.4) | 1 | 13 (61.9) | 1 | 1 | ||||||
| Formula | 6 (31.6) | 8 (38.1) | ||||||||||
| First week | Breastfeeding | 13 (68.4) | 1.00 | - | - | 14 (66.7) | 1.23 | 0.61-2.48 | 0.58 (.561) | 1.23 | 0.61-2.48 | 0.58 (.561) |
| Formula | 6 (31.6) | 7 (33.3) | ||||||||||
| Second week | Breastfeeding | 11 (57.9) | 0.63 | 0.35-1.16 | -1.48 (.138) | 12 (57.1) | 0.82 | 0.42-1.60 | -0.58 (.561) | 1.29 | 0.53-3.17 | 0.56 (.575) |
| Formula | 8 (42.1) | 9 (42.9) | ||||||||||
| Third week | Breastfeeding | 8 (42.1) | 0.34 | 0.14-0.80 | -2.48 (.013) | 12 (57.1) | 0.82 | 0.29-2.28 | -0.38 (.705) | 2.44 | 0.64-9.33 | 1.31 (.191) |
| Formula | 11 (57.9) | 9 (42.9) | ||||||||||
| Fourth week | Breastfeeding | 7 (36.8) | 0.27 | 0.11-0.68 | -2.76 (.006) | 13 (61.9) | 1.00 | 0.38-2.64 | 0.00 | 3.71 | 0.97-14.25 | 1.91 (.056) |
| Formula | 12 (63.2) | 8 (38.1) | (>.999) | |||||||||
Time effects using generalized estimating equations (GEEs) for each group;
Interaction effect between treatment (Cont. and Exp.) and time using a GEEs;
CI, confidence interval; Cont., control group; Exp., experimental group; OR, odds ratio.
Comparison of Growth and Transcutaneous Bilirubin Levels between the Groups Over Time (N=40)
| Variables | Time | Cont. (n=19) | Exp. (n=21) | t |
| Source | F |
|
|---|---|---|---|---|---|---|---|---|
| M±SD | M±SD | |||||||
| Body weight (g) | Discharge | 2,258±374 | 2,239±271 | 1.16 | .256 | Group | 2.11 | .154 |
| First week | 2,528±343 | 2,640±346 | 0.28 | .778 | Time | 363.38 | <.001 | |
| Second week | 2,842±317 | 3,004±384 | 1.07 | .289 | G*T | 5.69 | .011 | |
| Third week | 3,181±415 | 3,391±427 | 1.60 | .119 | ||||
| Fourth week | 3,483±576 | 3,847±441 | 2.36 | .024 | ||||
| Length (cm) | First week | 47.9±1.2 | 48.3±1.7 | 1.15 | .258 | Group | 3.69 | .062 |
| Second week | 48.8±1.4 | 49.4±1.5 | 1.35 | .184 | Time | 377.33 | <.001 | |
| Third week | 49.4±1.4 | 50.5±1.6 | 2.50 | .017 | G*T | 18.78 | <.001 | |
| Fourth week | 50.0±1.5 | 51.4±1.5 | 3.70 | .001 | ||||
| Head circumference (cm) | First week | 33.1±0.8 | 33.5±0.8 | 0.74 | .465 | Group | 6.25 | .017 |
| Second week | 33.8±0.8 | 34.3±0.9 | 1.57 | .125 | Time | 210.71 | <.001 | |
| Third week | 34.3±0.9 | 35.0±0.8 | 2.36 | .024 | G*T | 4.81 | .003 | |
| Fourth week | 34.8±0.8 | 35.8±0.9 | 4.04 | <.001 | ||||
| TcB (mg/dL) | Discharge | 8.82±3.38 | 6.11±3.07 | 2.30 | .027 | Group | 0.06 | .803 |
| First week | 6.02±4.04 | 3.98±2.50 | 2.78 | .009 | Discharge | 11.26 | .002 | |
| Second week | 4.38±3.31 | 3.22±2.71 | 2.27 | .029 | Time | 1.14 | .337 | |
| Third week | 3.95±3.19 | 2.71±2.81 | 2.44 | .019 | G*T | 1.03 | .384 | |
| Fourth week | 3.44±2.96 | 2.28±2.36 | 2.47 | .018 | D*T | 3.38 | .036 |
Cont., control group; D, discharge; Exp., experimental group; G, group; T, time; TcB, transcutaneous bilirubin.